News
Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...
The Clinical Presentation of Ehlers-Danlos Syndrome Elizabeth J. Lawrence, RNC, MSN, NNP Disclosures Adv Neonatal Care. 2005;5 (6):301-314.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback